Connect with us

Technology

Rice Biotech Launch Pad invents ‘living pharmacy’ designed to produce therapeutics inside the body

Published

on

Durable implant to enter clinic in 2027 has multiple applications and represents new therapeutic approach that lasts full year

HOUSTON, Oct. 2, 2026 /PRNewswire/ — Biologic medicines can be powerful treatments for many diseases, but their cost can limit access. According to the U.S. Food and Drug Administration, biologics account for just 5% of prescriptions but 51% of drug spending. Researchers at Rice University, with the support of the Rice Biotech Launch Pad, have developed an implantable “living pharmacy” using engineered protein producers (EPPs) that could one day deliver these medicines continuously for months or years from a single procedure.

According to the new study published in Science Advances titled “Once-yearly cell-based therapy for sustained and dose-tunable delivery of monoclonal antibodies,” engineered cells enclosed within a specially modified biomaterial continuously produced therapeutic monoclonal antibodies for one year across multiple preclinical models. The retrievable system also allowed researchers to stop treatment or adjust dosing by removing or replacing the implant.

The work addresses a key challenge for implantable cell therapies. The body’s foreign body response can cause inflammation and scar tissue to build up around an implant, restricting the movement of nutrients and therapeutic proteins and ultimately reducing cell survival and drug production.

“We have created an entirely new approach for the development and use of therapeutic antibodies,” said Robert S. Langer, co-founder of Duracyte and professor at the Massachusetts Institute of Technology. “By combining engineered cells, biomaterials and an implantable device, this approach has the potential to create a living pharmacy that provides long-lasting production of biologic medicines while maintaining a level of control that is important for therapeutic use.”

This platform is being developed by Duracyte, which is advancing the platform toward clinical development with the publication providing a foundation for further work on safety, biocompatibility, device design and therapeutic applications. The researchers also used human pharmacokinetic modeling to assess the potential for clinically relevant antibody levels and demonstrated a minimally invasive device designed to support dose adjustment and treatment cessation. Because EPPs can be engineered to produce different proteins, the platform could ultimately support a range of biologic medicines.

The platform was also designed to be adaptable across therapeutic targets. Researchers engineered the same human cell line to produce 13 different monoclonal antibodies spanning oncology, autoimmune disease and infectious disease, including ipilimumab, pembrolizumab, adalimumab, 3BNC117 and PGT121. The antibodies retained their intended biological activity, demonstrating the platform’s potential as a modular approach to mAb delivery.

“The potential of this platform is similar in some ways to the promise of reusable rockets for space travel which significantly reduced cost and time to manufacture,” said Omid Veiseh, professor of bioengineering at Rice University and corresponding author of the study. “Rather than repeatedly manufacturing and delivering a biologic from outside the body, EPPs could produce therapeutic proteins continuously inside the patient. If this approach can be successfully translated, it could offer a more efficient way to deliver biologics with the potential to reduce some of the costs associated with manufacturing and repeatedly administering these medicines.”

The potential economic impact comes at a time of growing concern over the cost and accessibility of biologic medicines. A recent report highlighted by The Wall Street Journal found that 90% of major biologic drugs expected to lose exclusivity over the next decade have no lower-cost competitors in development, underscoring the need for new approaches to how these medicines are produced and delivered.

The study was led by co-first authors Cody Fell, Anthony E. Davis and Shalini Pandey of the Department of Bioengineering at Rice in Houston. This work was supported by the Gates Foundation (INV-051204) and the Advanced Research Projects Agency-Health (AY1AX000003 and 1047648-490467).

This news release can be found online at news.rice.edu.

Follow Rice News and Media Relations via Twitter @RiceUNews.

Peer-reviewed paper:

Once-yearly cell-based therapy for sustained and dose-tunable delivery of monoclonal antibodies | Science Advances | DOI: 10.1126/sciadv.aej5440

Authors: Cody Fell, Anthony E Davis, Shalini Pandey, Michael T Guinn, Zeshi Wang, Jonathon DeBonis, Chancellor Smith, Nathan Brown, Danna Murungi, Yeonju Kim, Imaan Mohandessi, Patrick Bednarz, Amir Ardeshir, Erin M Haupt, Samuel I Cuevas, Christy L Lavine, Michael S Seaman, Oleg Igoshin, Ravi K Ghanta, Michael R Diehl, Omid Veiseh

About Rice:

Located on a 300-acre forested campus in Houston, Texas, Rice University is consistently ranked among the nation’s top 20 universities by U.S. News & World Report. Rice has highly respected schools of architecture, business, continuing studies, engineering and computing, humanities, music, natural sciences and social sciences and is home to the Baker Institute for Public Policy. Internationally, the university maintains the Rice Global Paris Center, a hub for innovative collaboration, research and inspired teaching located in the heart of Paris. With 4,776 undergraduates and 4,104 graduate students, Rice’s undergraduate student-to-faculty ratio is just under 6-to-1. Its residential college system builds close-knit communities and lifelong friendships, just one reason why Rice is ranked No. 1 for lots of race/class interaction and No. 7 for best-run colleges by the Princeton Review. Rice is also rated as a best value among private universities by the Wall Street Journal and is included on Forbes’ exclusive list of “New Ivies.”

If you do not wish to receive news releases from Rice University, reply to this email and write “unsubscribe” in the subject line. Office of News and Media Relations – MS 300, Rice University, 6100 Main St., Houston, TX 77005.

About the Rice Biotech Launch Pad:  

The Rice Biotech Launch Pad is a Houston-based accelerator focused on expediting the translation of Rice University’s health and medical technology discoveries into cures. This initiative is designed to help advance internally discovered platform technologies from concept to clinical studies and commercialization. The Rice Biotech Launch Pad will identify and support highly differentiated projects while driving the expansion of Houston as a world-class medical innovation ecosystem. The accelerator will bring together local researchers with a network of industry executives. For more information, please visit https://biotechlaunchpad.rice.edu/.

Media Contact:

Russo Partners
David Schull or Liz Phillips
(347) 956-7697
david.schull@russopartnersllc.com 
elizabeth.phillips@russopartnersllc.com

 

View original content:https://www.prnewswire.com/news-releases/rice-biotech-launch-pad-invents-living-pharmacy-designed-to-produce-therapeutics-inside-the-body-302896947.html

SOURCE Rice University

Continue Reading

Technology

AI Revenue Questions Pull Semiconductor Stocks Off October Highs

Published

on

By

VANCOUVER, BC, Oct. 10, 2026 /PRNewswire/ — Stock Preachers News Commentary – Semiconductor equities began October on firm footing, with the iShares Semiconductor ETF advancing for five consecutive sessions and the sector’s largest company reaching a record high, before retreating through the week ended October 9. Sentiment shifted on Thursday, when the Financial Times reported that OpenAI had told investors its annualized revenue was nearing $50 billion at the end of September, below the approximately $70 billion figure that had been cited in media reports. Because semiconductor valuations are closely tied to expectations for AI infrastructure spending, the report weighed on the group, and the PHLX Semiconductor Index finished the week lower while the broader market was more resilient. Active Companies from around the markets with current developments this week include: Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM), NVIDIA Corporation (NASDAQ: NVDA), Intel Corporation (NASDAQ: INTC), Arm Holdings plc (NASDAQ: ARM), Micron Technology, Inc. (NASDAQ: MU).

The pullback follows a period of substantial gains. The PHLX Semiconductor Index was up 73% year to date as of late September, and several of the sector’s largest constituents have recorded triple-digit gains in 2026. Higher long-term Treasury yields and a rise in crude oil prices added pressure midweek, as higher discount rates tend to weigh most on companies valued on long-term growth expectations.

Company-specific developments shaped performance within the group. Two companies reported record milestones early in the week, while others faced open questions regarding a manufacturing partnership, ongoing litigation and the sustainability of AI-related demand.

CONTINUED… Read the full weekly market analysis in The Roadmap at: stockpreachers.com

In other industry developments and happenings in the market this week include:

Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM)

TSMC shares reached a record high on October 5 after Elon Musk confirmed early-stage discussions about a role for the company in his planned Terafab chip complex in Texas, calling them “just discussions.” On October 8 the company reported September revenue of NT$511.86 billion, up 54.6% from a year earlier and down 0.6% from August, bringing revenue for the first nine months of 2026 to NT$3.90 trillion, up 41.1%.

NVIDIA Corporation (NASDAQ: NVDA)

NVIDIA shares reached a record high on October 5, bringing their year-to-date gain to approximately 24.8% and their advance since the August 26 earnings report to approximately 14%. The company has also shown relative strength during recent sector weakness: on September 28, when semiconductor shares declined on AI safety concerns, NVIDIA advanced after announcing a $150 billion share buyback authorization and releasing two open-source tools designed to help control AI agents.

Intel Corporation (NASDAQ: INTC)

Intel shares declined on October 5 after Musk indicated that TSMC could participate in Terafab, a project Intel joined as a partner in April. On October 8 Musk said his companies will build and operate the Texas complex and that another chipmaker could at most sublease part of the site. Intel has said it will remain involved, although the scope of its role has not been finalized. Despite the decline, Intel shares were up approximately 215% year to date as of the October 5 close.

Arm Holdings plc (NASDAQ: ARM)

Arm shares declined during a five-day jury trial in federal court in Wilmington, Delaware, where Qualcomm alleges that Arm breached their licensing agreements and sought to undermine Qualcomm’s dealings with Meta Platforms. Arm denies the claims. The case went to the jury on October 9, and the judge has not yet ruled on whether a clause that could let Qualcomm stop paying royalties for five years is enforceable. Arm reports earnings on November 4.

Micron Technology, Inc. (NASDAQ: MU)

Micron shares declined alongside other memory producers despite Rosenblatt raising its price target to $1,900 from $1,500 on October 6, citing a beat-and-raise quarter and the potential for buybacks. Memory producers had advanced with the broader group in early October before sentiment shifted later in the week.

———————————————-

Luxor IQ by Quote Daddy

Researching a stock normally means piecing together prices, financials, news and analyst views across a dozen tabs. Luxor IQ by Quote Daddy does it in one step. Enter a U.S. ticker and it turns live prices, a year of trend data, fundamentals, news and analyst ratings into a clear research note written by AI, covering valuation, financial health and key risks. You can run three reports a day free on the web or in the Quote Daddy app at ai.quotedaddy.com

Contact Information:
https://stockpreachers.com/
Media Contact: info@stockpreachers.com

DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a market commentary and is not a paid advertisement. It is neither an offer nor a recommendation to buy or sell any security.

This article is being distributed by Stock Preachers, which is wholly owned and operated by Market Equities Limited (“MEL”), a company incorporated under the laws of Ireland. This is an independent market commentary published on a non-paid basis. MEL has not been paid any fee by any company mentioned in this article for its production or distribution, and MEL has no advertising or digital media agreement with any company mentioned in this article. The companies mentioned have not reviewed or approved this article.

Market Equities and its owners, operators, directors, and affiliates may, from time to time, hold positions in securities mentioned in this article or in the broad-market index funds that track them, and reserve the right to buy, sell, or hold such securities at any time without further notice.

Information in this article was obtained from sources believed to be reliable, including company news releases and filings and public reporting on market prices, analyst actions and legal proceedings, but its accuracy cannot be guaranteed. Investing in securities involves risk, including the possible loss of some or all of your investment.

References to the companies named in this article are provided solely as market and sector context and as summaries of public reporting and company disclosures. No partnership, affiliation, or endorsement is implied, and nothing in this article is a recommendation to buy, sell, or hold any security. Analyst price targets cited are those of third parties. The outcome of the legal proceedings and partnership discussions described cannot be predicted.

Forward-Looking Statements: This article may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements made by the companies mentioned in their own news releases. Such statements involve risks and uncertainties, and actual results may differ materially. Readers should review each company’s filings with the SEC.

Luxor IQ Disclosure. Luxor IQ is a research tool from Quote Daddy, a stock-tracking application affiliated with the publisher of this article, and this reference constitutes promotion of an affiliated product. Luxor IQ reports are generated by artificial intelligence, may contain errors, and are for informational and educational purposes only. Nothing in them is financial, investment, tax, or legal advice. Always do your own research before making any investment decision.

SOURCE Stock Preachers

View original content:https://www.prnewswire.com/news-releases/ai-revenue-questions-pull-semiconductor-stocks-off-october-highs-302905067.html

Continue Reading

Technology

Church of Scientology International’s Scientology Network Marks World Mental Health Day with CCHR Documentary Marathon

Published

on

By

LOS ANGELES, Oct. 10, 2026 /PRNewswire/ — On World Mental Health Day, October 10, Scientology Network presents a marathon event spotlighting the Citizens Commission on Human Rights (CCHR). The program features CCHR’s mission to expose psychiatric industry corruption and combat human rights abuses.

The World Mental Health Day Marathon on Scientology Network features three CCHR documentaries and Voices for Humanity.

This focus comes at a critical moment, as concerns over the potential links between psychiatric drugs, suicide, aggression and violence have thrust the issue of psychiatric drugging into the public eye.

Founded in 1969, CCHR is a nonprofit mental health watchdog responsible for helping to enact nearly 400 laws protecting individuals from abusive or coercive practices.

The World Mental Health Day Marathon will feature:

CCHR documentaries—an ongoing investigative series confronting powerful psychiatric groups to reveal corruption and the alarming history of abuses. The films included are:Psychiatry: An Industry of Death —An investigation of psychiatry’s dark past.Making a Killing —Examining the “unholy alliance” between the psychiatric industry, Big Pharma and government regulators.Prescription for Violence: Psychiatry’s Deadly Side Effects — Examining the potential link between rising psychiatric drug prescriptions and acts of violence and suicide.Voices for Humanity—the only ongoing television series dedicated to showcasing everyday people leading grassroots efforts to promote human rights, educate youth on the dangers of drugs and combat psychiatric abuse.Documentary Showcase: Letters from Generation Rx—An Award-winning documentary that exposes the dangerous and devastating effects of antidepressants, antipsychotics and other drugs marketed by pharmaceutical companies as “safe and effective.”

The World Mental Health Day Marathon starts October 10 at 8 a.m. ET.

Learn the truth about the psychiatric industry. Visit cchr.org for more information, and see the full marathon schedule at scientology.tv/schedule.

Scientology Network debuted on March 12, 2018, launched by David Miscavige, ecclesiastical leader of the Scientology religion. Since then, Scientology Network has been viewed in over 240 countries and territories worldwide in 17 languages. Satisfying the curiosity of people about Scientology, the network takes viewers across six continents, spotlighting the everyday lives of Scientologists, showing the Church as a global organization and presenting its Social Betterment programs that have touched the lives of millions worldwide. The network also showcases documentaries by independent filmmakers who represent a cross section of cultures and faiths, but share a common purpose of uplifting communities. Scientology Network’s innovative content has been recognized with more than 175 industry awards, including Tellys, Communitas and Hermes Creative Awards.

Broadcast from Scientology Media Productions, the Church’s global media center in Los Angeles, Scientology Network is available on DIRECTV Channel 320, DIRECTV STREAM and AT&T U-verse and can be streamed at scientology.tv, on mobile apps and via the Roku, Amazon Fire and Apple TV platforms.

View original content to download multimedia:https://www.prnewswire.com/news-releases/church-of-scientology-internationals-scientology-network-marks-world-mental-health-day-with-cchr-documentary-marathon-302905064.html

SOURCE Church of Scientology International

Continue Reading

Technology

Emdoor Information Marks 18 Years of Rugged Computing Excellence with Vertically Integrated Capabilities

Published

on

By

SHENZHEN, China, Oct. 10, 2026 /PRNewswire/ — As industrial automation, smart manufacturing, and field operations increasingly depend on mission-critical mobile computing, global demand for reliable rugged tablets, rugged laptops, and rugged handhelds continues to accelerate. Emdoor Information, a publicly listed company on China’s A-share main board since 2023 and an 18-year veteran in rugged computing, has established itself as a rugged computing solutions provider for industrial customers worldwide. Founded in 2008, the company delivers sustained growth, world-class manufacturing, resilient supply chains, full-stack R&D, and comprehensive lifecycle services. Its rugged computing products and industrial customers now span North America, Latin America, Europe, and Asia-Pacific, serving sectors such as public utilities, intelligent manufacturing, warehouse management, transportation, energy industry.

Financial Strength & Governance: Listed and Well Governed

Emdoor Information’s financial performance reflects the durability of its business model. Listed on China’s A-share main board in 2023, the company reported 2025 revenue of RMB 4.583 billion (approximately USD 640 million), up 44.15% year over year. This growth is driven by disciplined governance and sustained innovation: R&D staff account for over 40% of the workforce, and cumulative R&D investment over the past five years reached RMB 964 million, a compound annual growth rate of 15.9%. As a publicly listed company with transparent reporting, Emdoor Information offers industrial customers and channel partners the governance stability needed for long-term cooperation.

Integrated Manufacturing & Quality: Own Lines, 7.8M Units

Emdoor Information owns its self-built Emdoor Building, which includes corporate offices and a 20,000-square-meter intelligent manufacturing base. The base has four production floors, 15 integrated assembly and testing lines, and an annual capacity of 7.8 million units. Co-locating manufacturing and R&D within the headquarters enables rapid design validation and faster time-to-market. The facility holds ISO five-system certification and uses advanced automation, including AI-powered visual inspection and Manufacturing Execution Systems (MES) for full-process traceability.

The Emdoor Building also houses a reliability testing base backed by tens of millions of RMB in investment, with dedicated labs for waterproofing, drop testing, environmental simulation, and mechanical durability. All rugged tablets, laptops, and handheld terminals undergo rigorous validation against IP ratings and MIL-STD-810 standards, ensuring reliable operation under extreme field conditions.

Supply Chain Resilience: Steady Supply, Controlled Costs

Emdoor Information’s supply chain is anchored by long term partnerships with global semiconductor and technology leaders, including Intel, Qualcomm, and Rockchip. These relationships, recognized by honors such as Intel Premium Partner and Microsoft ODM Strategic Champion, provide early access to platform level technical resources and prioritized supply allocation.

The company centralizes component procurement through its group supply chain management center. With annual procurement in the hundreds of millions of RMB, this approach optimizes hardware Bill of Materials (BOM) costs while maintaining tier one supplier quality. To mitigate volatility, especially in memory and storage, Emdoor maintains strategic bulk inventory and dynamic safety stock across critical materials. This discipline is supported by a rolling finished goods inventory valued at RMB 120 million, enabling delivery of standard configurations in one to three days and customized units in seven to thirty days. As a result, the company ensures stable pricing, controlled cost fluctuations, and protection of customer project margins.

Full Stack R&D & Product Innovation: 100 Models, 5 Platforms, 3 OS

Emdoor Information offers a broad product portfolio: rugged tablets and laptops, rugged handhelds, vehicle mounted computers, and industrial panel PCs from 4 to 21.5 inches. It supports five platforms, Intel, AMD, Qualcomm, MediaTek, and Rockchip, across Windows, Android, and Linux. With nearly 100 models in active production, the company matches precise configurations to industrial scenarios such as quality inspection, intelligent patrol, and edge computing.

These platforms are often specified among the best rugged tablet, laptop, vehicle mount tablet, and industrial panel PC solutions for mission critical operations. A key strength is full stack internal development, covering industrial design, structural engineering, hardware architecture, software integration, and validation testing. All products carry international certifications including CCC, CE, FCC, RoHS, GMS, and UN38.3, plus specialized certifications for hazardous environments and automotive deployments.

On software, devices ship with pre-installed productivity tools such as physical key remapping, kiosk mode, and granular system controls. The integrated Mobile Device Management (MDM) platform enables fleet wide deployment, batch configuration, and remote control. Open SDK and API access for modules like barcode scanning facilitates rapid secondary development and enterprise integration, eliminating the need to build adapter frameworks from scratch. Beyond standard configurations, Emdoor provides rugged devices customization across hardware, software, and structural redesign for specialized operational needs.

Lifecycle Service Excellence: Worldwide Reach, Lasting Alliances

Recognizing that enterprise and industrial computing deployments often operate on lifecycles of five to ten years, Emdoor Information has built a service architecture for long term reliability. It provides repair services in Hong Kong. Technical support is available through a dedicated hotline, official social media, email, and an online support system with full lifecycle traceability from issue submission to resolution.

The company offers structured maintenance training to help customer engineering teams manage devices autonomously. It also operates a continuous feedback mechanism with after sales follow up and annual satisfaction surveys. Insights from frontline customers are integrated into product development, keeping device capabilities and service delivery aligned with field needs. For channel and distribution partners, Emdoor provides market development support including marketing collateral, agent training, industry salons, and trade show facilitation. Sales enablement includes project registration, territorial protection, and flexible inventory allocation, creating a full spectrum collaboration framework from pre sales consultation to long term after sales engagement.

Conclusion

Backed by financial strength & governance, integrated manufacturing & quality, supply chain resilience, full-stack R&D & product innovation and lifecycle service excellence, Emdoor Information has built a global partner network across multiple continents and earned recognition from customers in industrial automation, logistics, transportation, and field service. “Our growth reflects not only market demand but also the strength of our vertically integrated model, from manufacturing and supply chain to R&D and lifecycle services,” said a company spokesperson. Looking ahead, Emdoor Information remains committed to deepening its rugged computing expertise, optimizing product performance and service delivery, and expanding worldwide. Its vision is to become a leading global provider of rugged computing solutions, delivering reliable, mission critical devices for the most demanding environments.

About Emdoor Information

Emdoor Information (SZ: 001314) specializes in providing high-quality rugged mobile computing devices and customized solutions for industry clients worldwide. Its portfolio includes rugged handhelds, rugged tablets, rugged notebooks, vehicle PCs, and industrial panel PCs. For more information, visit www.emdoorrugged.com. Follow us on LinkedIn, YouTube, and Facebook.

View original content to download multimedia:https://www.prnewswire.com/news-releases/emdoor-information-marks-18-years-of-rugged-computing-excellence-with-vertically-integrated-capabilities-302905039.html

SOURCE Emdoor Information

Continue Reading

Trending